Trial intelligence / Profile preview

Single-dose dexamethasone and/or surfactant lavage for severe meconium aspiration syndrome

2005-002687-29Phase 3Active

Sponsor
XAVIER CARBONELL ESTRANY
Start
Apr 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of dexamethasone in Meconium aspiration syndrome (MAS) (3 arms), sponsored by XAVIER CARBONELL ESTRANY. Primary endpoint: Primary efficacy endpoint. Started Apr 2006; status: active.

02

Drugs

dexamethasone
03

Conditions

Meconium aspiration syndrome (MAS)

Beyond the preview

Go deeper on 2005-002687-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002687-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call